MX2008011321A - Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. - Google Patents
Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual.Info
- Publication number
- MX2008011321A MX2008011321A MX2008011321A MX2008011321A MX2008011321A MX 2008011321 A MX2008011321 A MX 2008011321A MX 2008011321 A MX2008011321 A MX 2008011321A MX 2008011321 A MX2008011321 A MX 2008011321A MX 2008011321 A MX2008011321 A MX 2008011321A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- sexually transmitted
- transmitted infections
- treating sexually
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica oral sólida que comprende fluconazol, tinidazol y clindamicina o una sal farmacéuticamente aceptable de los mismos, donde el contenido de excipientes farmacéuticamente aceptables es significativamente menor que el contenido que los principios activos, el uso de dicha composición para 1a administración oral con actividad terapéutica para el tratamiento de infecciones de transmisión sexual.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2008011321A MX2008011321A (es) | 2008-09-04 | 2008-09-04 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. |
KR1020117006146A KR101653424B1 (ko) | 2008-09-04 | 2009-09-04 | 성전염성 감염 치료에 사용하기 위한 약학적 조성물 |
EP09811170.1A EP2329819B1 (en) | 2008-09-04 | 2009-09-04 | Pharmaceutical composition for use in treating sexually transmitted infections |
PCT/IB2009/006738 WO2010026469A1 (es) | 2008-09-04 | 2009-09-04 | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual |
PE2011000439A PE20110448A1 (es) | 2008-09-04 | 2009-09-04 | Composicion farmaceutica que comprende: fluconazol, tinidazol y clindamicina |
CA2735926A CA2735926C (en) | 2008-09-04 | 2009-09-04 | Pharmaceutical composition for use in treating sexually transmitted infections |
ES09811170T ES2734280T3 (es) | 2008-09-04 | 2009-09-04 | Composición farmacéutica para su uso en el tratamiento de infecciones de transmisión sexual |
UY0001032091A UY32091A (es) | 2008-09-04 | 2009-09-04 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual |
BRPI0918593A BRPI0918593B8 (pt) | 2008-09-04 | 2009-09-04 | composição farmacêutica para uso no tratamento de infecções sexualmente transmitidas |
US13/062,182 US20110166087A1 (en) | 2008-09-04 | 2009-09-04 | Pharmaceutical composition for use in treating sexually transmitted infections |
HN2011000661A HN2011000661A (es) | 2008-09-04 | 2011-03-03 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual |
CO11036830A CO6321156A2 (es) | 2008-09-04 | 2011-03-25 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual |
EC2011010941A ECSP11010941A (es) | 2008-09-04 | 2011-04-01 | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2008011321A MX2008011321A (es) | 2008-09-04 | 2008-09-04 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008011321A true MX2008011321A (es) | 2010-03-04 |
Family
ID=41796784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008011321A MX2008011321A (es) | 2008-09-04 | 2008-09-04 | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20110166087A1 (es) |
EP (1) | EP2329819B1 (es) |
KR (1) | KR101653424B1 (es) |
BR (1) | BRPI0918593B8 (es) |
CA (1) | CA2735926C (es) |
CO (1) | CO6321156A2 (es) |
EC (1) | ECSP11010941A (es) |
ES (1) | ES2734280T3 (es) |
HN (1) | HN2011000661A (es) |
MX (1) | MX2008011321A (es) |
PE (1) | PE20110448A1 (es) |
UY (1) | UY32091A (es) |
WO (1) | WO2010026469A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113768883A (zh) * | 2021-08-25 | 2021-12-10 | 海南海神同洲制药有限公司 | 一种高稳定性盐酸克林霉素棕榈酸酯颗粒的制备方法 |
CN113768885A (zh) * | 2021-09-16 | 2021-12-10 | 海南海神同洲制药有限公司 | 一种伏立康唑干混悬剂的制备工艺 |
CN114306209A (zh) * | 2022-01-10 | 2022-04-12 | 江苏远恒药业有限公司 | 一种替硝唑栓的组合物及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7094431B2 (en) | 2000-10-12 | 2006-08-22 | Mickey L. Peshoff | Method of healing skin wounds in mammals and a composition therefor |
MXPA02007641A (es) * | 2002-08-08 | 2004-04-02 | Alparis Sa De Cv | Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral. |
US8309103B2 (en) * | 2004-01-22 | 2012-11-13 | Alparis, S.A. De C.V. | Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
CA2635994A1 (en) * | 2006-01-05 | 2007-07-12 | Drugtech Corporation | Drug delivery system for bioadhesion to a vulvovaginal surface |
US20080003262A1 (en) * | 2006-06-30 | 2008-01-03 | Drugtech Corporation | Compositions and therapeutic methods of use |
-
2008
- 2008-09-04 MX MX2008011321A patent/MX2008011321A/es active IP Right Grant
-
2009
- 2009-09-04 BR BRPI0918593A patent/BRPI0918593B8/pt active IP Right Grant
- 2009-09-04 UY UY0001032091A patent/UY32091A/es not_active Application Discontinuation
- 2009-09-04 KR KR1020117006146A patent/KR101653424B1/ko active IP Right Grant
- 2009-09-04 PE PE2011000439A patent/PE20110448A1/es active IP Right Grant
- 2009-09-04 EP EP09811170.1A patent/EP2329819B1/en not_active Not-in-force
- 2009-09-04 US US13/062,182 patent/US20110166087A1/en not_active Abandoned
- 2009-09-04 ES ES09811170T patent/ES2734280T3/es active Active
- 2009-09-04 WO PCT/IB2009/006738 patent/WO2010026469A1/es active Application Filing
- 2009-09-04 CA CA2735926A patent/CA2735926C/en active Active
-
2011
- 2011-03-03 HN HN2011000661A patent/HN2011000661A/es unknown
- 2011-03-25 CO CO11036830A patent/CO6321156A2/es not_active Application Discontinuation
- 2011-04-01 EC EC2011010941A patent/ECSP11010941A/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20110050678A (ko) | 2011-05-16 |
UY32091A (es) | 2010-02-26 |
BRPI0918593A2 (pt) | 2018-05-22 |
CO6321156A2 (es) | 2011-09-20 |
EP2329819A1 (en) | 2011-06-08 |
ECSP11010941A (es) | 2011-06-30 |
CA2735926A1 (en) | 2010-03-11 |
ES2734280T3 (es) | 2019-12-05 |
BRPI0918593B8 (pt) | 2021-05-25 |
BRPI0918593A8 (pt) | 2018-12-11 |
HN2011000661A (es) | 2013-09-16 |
WO2010026469A1 (es) | 2010-03-11 |
CA2735926C (en) | 2016-09-06 |
US20110166087A1 (en) | 2011-07-07 |
KR101653424B1 (ko) | 2016-09-01 |
EP2329819B1 (en) | 2019-05-01 |
PE20110448A1 (es) | 2011-07-20 |
BRPI0918593B1 (pt) | 2020-11-10 |
EP2329819A4 (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
NZ714963A (en) | Compositions and methods for treating anemia | |
NZ599847A (en) | Pharmaceutical composition comprising a glp-1 agonist and methionine | |
NZ702801A (en) | Treatment of sanfilippo syndrome type b | |
NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
JP2010222367A5 (es) | ||
MX2009002314A (es) | Composiciones farmaceuticas que comprenden hgh para suministro oral. | |
MX2010009623A (es) | Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
MX2007007504A (es) | Composiciones terapeuticas para la administracion intranasal de ketorolaco. | |
NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
NZ599265A (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
HK1176318A1 (en) | Injection device | |
TN2012000531A1 (en) | Substituted heterocyclyl benzyl pyrazoles, and use thereof | |
MX2010009624A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. | |
NZ595376A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
MX345032B (es) | Antagonistas del receptor ep4 para el tratamiento de cáncer. | |
MX2009011900A (es) | Curacion de herida diabetica. | |
WO2011074015A3 (en) | Composition of pharmaceutical product to treat sexual dysfunction | |
MX2013000694A (es) | Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb. | |
AR061233A1 (es) | Formulacion de liberacion prolongada de naltrexona | |
MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
MX2008011321A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |